IP Library › Patent Application 13939224
Patent Application
App. No. 13/939,224

THERAPEUTIC DELIVERY SYSTEM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/939,224
Abstract

Therapeutic delivery systems are provided which, in a first embodiment, contain a plurality of multiphase capsules in which first and second therapeutic agents are contained in separate phases within said multiphase capsules, and are disposed to deliver said first and therapeutic agents by at least two different delivery mechanisms.

Claims (9)

1 . A therapeutic delivery system comprising a plurality of multiphase capsules, said multiphase capsules containing first and second therapeutic agents disposed in separate phases within said multiphase capsules to deliver said first and second therapeutic agents by at least two different delivery mechanisms.

2 . The therapeutic delivery system of claim 1 wherein said first therapeutic agent is delivered by a topical administration, and said second therapeutic agent is delivered by a mechanism which is not topical administration.

3 . The therapeutic delivery system of claim 1 wherein said first therapeutic agent comprises one or more of: antibiotics, wound healing agents, vasodilators, coagulants, birth control drugs, cardiovascular drugs, chemotherapeutic agents, vitamins, antiviral agents, anti-microbial agents, analgesics, anti-inflammatory agents, steroidal agents, hydrocortisone, triamcinolone, non-steroidal agents, ibuprofen, naproxen, flufenamic acid, mefenamic acid, meclofenamic acid, prioxicam and felbinac, transdermal decongestants and antihistamines.

4 . The therapeutic delivery system of claim 1 wherein said multiphase capsules provide at least one phase capable of reincapsulation.

5 . The therapeutic delivery system of claim 1 wherein said multiphase capsules have a diameter of about 0.001 micron to about 50 microns.

6 . The therapeutic delivery system of claim 1 wherein said multiphase capsules comprise a cyclodextrine, waxy material, fatty material, polymer, or a combination thereof.

7 . The therapeutic delivery system of claim 1 wherein said multiphase capsules comprise a double encapsulation.

8 . The therapeutic delivery system of claim 1 wherein said multiphase capsules release said first therapeutic agent, said second therapeutic agent, or both, upon a change in pH.

9 . The therapeutic delivery system of claim 2 wherein said second therapeutic agent comprises a fragrance oil.